Capstone Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$823K Buy
9,100
+1,900
+26% +$174K ﹤0.01% 924
2025
Q4
$647K Sell
7,200
-2,700
-27% -$256K ﹤0.01% 1046
2025
Q3
$975K Buy
9,900
+1,200
+14% +$119K ﹤0.01% 1038
2025
Q2
$794K Sell
8,700
-9,100
-51% -$880K ﹤0.01% 937
2025
Q1
$2.01M Sell
17,800
-7,100
-29% -$760K 0.01% 682
2024
Q4
$2.63M Buy
24,900
+8,800
+55% +$944K 0.01% 761
2024
Q3
$1.74M Sell
16,100
-2,200
-12% -$240K 0.01% 781
2024
Q2
$1.99M Buy
18,300
+3,600
+24% +$424K 0.01% 725
2024
Q1
$1.94M Sell
14,700
-3,800
-21% -$475K 0.01% 798
2023
Q4
$2.25M Buy
18,500
+13,500
+270% +$1.51M 0.01% 765
2023
Q3
$561K Buy
5,000
+2,400
+92% +$305K ﹤0.01% 1260
2023
Q2
$379K Hold
2,600
﹤0.01% 1294
2023
Q1
$336K Buy
+2,600
New +$326K ﹤0.01% 1142
2022
Q4
Sell
-30,700
Closed -$3.21M 1685
2022
Q3
$3.21M Buy
30,700
+900
+3% +$98.8K 0.02% 553
2022
Q2
$3.13M Sell
29,800
-40,100
-57% -$4.76M 0.02% 578
2022
Q1
$8.94M Sell
69,900
-32,585
-32% -$3.93M 0.02% 499
2021
Q4
$12.6M Sell
102,485
-15,553
-13% -$2.04M 0.02% 537
2021
Q3
$16.8M Buy
118,038
+41,200
+54% +$6.06M 0.03% 467
2021
Q2
$12M Buy
76,838
+40,582
+112% +$6.57M 0.03% 478
2021
Q1
$5.63M Buy
36,256
+22,660
+167% +$3.51M 0.02% 619
2020
Q4
$2.03M Buy
13,596
+12,154
+843% +$1.72M 0.01% 866
2020
Q3
$191K Buy
+1,442
New +$188K ﹤0.01% 1286

Other funds holding ZBH

Capstone Investment Advisors's ZBH Position: Q1 2026 in Review

Capstone Investment Advisors reduced its Zimmer Biomet (ZBH) stake by 46% in Q1 2026, selling an estimated $204K and leaving 2,591 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Capstone Investment Advisors first reported a position in ZBH in Q2 2014 and has held it in 24 quarters since. The position peaked at $5.05M in Q4 2021. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Capstone Investment Advisors held 2,591 shares of Zimmer Biomet worth $234K as of Q1 2026.
  • Capstone Investment Advisors sold 2,220 Zimmer Biomet shares in Q1 2026, an estimated $204K.
  • Zimmer Biomet made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1474 holding.
  • Capstone Investment Advisors first reported a position in Zimmer Biomet in Q2 2014 and has held it in 24 quarters since.
  • Capstone Investment Advisors's Zimmer Biomet position peaked at $5.05M in Q4 2021.
  • 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.